SureTrader SureTrader SureTrader
Home > Boards > US Listed > Medical - Drugs > Galena Biopharma (GALE)

I sold my last shares of Gale this

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
noretreat Member Profile
 
Followed By 123
Posts 9,445
Boards Moderated 2
Alias Born 01/06/10
160x600 placeholder
Amended Statement of Ownership (sc 13g/a) "Edgar (US Regulatory)" - 1/11/2017 10:44:28 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 1/9/2017 7:29:37 AM
Galena Biopharma to Provide Corporate and Clinical Update and 2017 Outlook During Presentation at Biotech Showcase 2017 "GlobeNewswire Inc." - 1/5/2017 7:05:00 AM
Galena Biopharma Confirms Regulatory Pathway for GALE-401 (Anagrelide Controlled Release) "GlobeNewswire Inc." - 12/28/2016 7:05:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 12/22/2016 5:31:23 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 12/20/2016 5:13:58 PM
Galena Biopharma Announces the Phase 2 Clinical Trial of NeuVax™ (nelipepimut-S) in Ductal Carcinoma in Situ (DCIS) is Open... "GlobeNewswire Inc." - 12/14/2016 7:05:00 AM
Galena Biopharma Presented Two Posters at the San Antonio Breast Cancer Symposium "GlobeNewswire Inc." - 12/12/2016 7:05:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 12/1/2016 4:39:56 PM
Galena Biopharma to Present Two Posters at the San Antonio Breast Cancer Symposium "GlobeNewswire Inc." - 11/30/2016 1:31:46 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 11/15/2016 6:28:02 PM
Initial Statement of Beneficial Ownership (3) "Edgar (US Regulatory)" - 11/15/2016 6:23:29 PM
Galena Biopharma Presents GALE-301/GALE-302 Phase 1b Data at the Society for Immunotherapy of Cancer Conference 2016 "GlobeNewswire Inc." - 11/14/2016 7:05:00 AM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 11/9/2016 5:02:57 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 11/9/2016 4:52:31 PM
Galena Biopharma Reports Third Quarter 2016 Financial Results and Provides a Corporate Update "GlobeNewswire Inc." - 11/9/2016 4:10:00 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 11/3/2016 4:31:24 PM
Galena Biopharma Appoints Stephen F. Ghiglieri as Executive Vice President and Chief Financial Officer "GlobeNewswire Inc." - 11/3/2016 7:05:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 10/31/2016 4:33:56 PM
Galena Biopharma Announces Reverse Stock Split "GlobeNewswire Inc." - 10/31/2016 4:30:00 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 10/26/2016 5:18:54 PM
Galena Biopharma to Report Third Quarter 2016 Financial Results and Provide a Corporate Update on Wednesday, November 9, 2016... "GlobeNewswire Inc." - 10/26/2016 7:05:00 AM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) "Edgar (US Regulatory)" - 10/20/2016 4:07:26 PM
Galena Biopharma Presents GALE-301/GALE-302 Phase 1b Data at the American College of Surgeons Clinical Congress 2016 "GlobeNewswire Inc." - 10/20/2016 7:05:00 AM
Notice of Effectiveness (effect) "Edgar (US Regulatory)" - 10/20/2016 6:01:52 AM
noretreat   Friday, 02/14/14 10:25:43 AM
Re: None
Post # of 10016 
I sold my last shares of Gale this morning, after lightening up by 90% over the previous month. It looks like these issues aren't going to go away quickly, and management does not seem to want to address them. Riding the run-up was nice.

Does not look like the CLDX of 2014 anymore, but who knows? There should be a bounce here a some point.


Men fear thought as they fear nothing else on earth -- more than ruin, more even than death. Thought is subversive and revolutionary, destructive and terrible, thought is merciless to privilege, established institutions, and comfortable habits.(Russell)
SureTrader
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist